A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division ...

The Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Miní, a wild-born female jaguar, takes an unbelievable journey from the Iberá Wetlands to the Gran Chaco forest to revive a ...

I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.

If you’re building out your bourbon collection, it’s easy to be overwhelmed by all the options out there. Rest easy, this is ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...